Cargando…
Pharmacokinetic Modeling of [(11)C]GSK-189254, PET Tracer Targeting H(3) Receptors, in Rat Brain
[Image: see text] The histamine H(3) receptor has been considered as a target for the treatment of various central nervous system diseases. Positron emission tomography (PET) studies with the radiolabeled potent and selective histamine H(3) receptor antagonist [(11)C]GSK-189254 in rodents could be u...
Autores principales: | Ghazanfari, Nafiseh, van Waarde, Aren, Doorduin, Janine, Sijbesma, Jürgen W. A., Kominia, Maria, Koelewijn, Martin, Attia, Khaled, Willemsen, Antoon T. M., Visser, Ton J., Heeres, André, Dierckx, Rudi A. J. O., de Vries, Erik F. J., Elsinga, Philip H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905578/ https://www.ncbi.nlm.nih.gov/pubmed/35170965 http://dx.doi.org/10.1021/acs.molpharmaceut.1c00889 |
Ejemplares similares
-
Binding of the Dual-Action Anti-Parkinsonian Drug
AG-0029 to Dopamine D(2) and Histamine H(3) Receptors:
A PET Study in Healthy Rats
por: Ghazanfari, Nafiseh, et al.
Publicado: (2022) -
Is cyclooxygenase‐1 involved in neuroinflammation?
por: Ghazanfari, Nafiseh, et al.
Publicado: (2021) -
Measuring serotonin synthesis: from conventional methods to PET tracers and their (pre)clinical implications
por: Visser, Anniek K. D., et al.
Publicado: (2010) -
Hunting for the high‐affinity state of G‐protein‐coupled receptors with agonist tracers: Theoretical and practical considerations for positron emission tomography imaging
por: Shalgunov, Vladimir, et al.
Publicado: (2018) -
Effect of Dopamine D(2) Receptor Antagonists
on [(18)F]-FEOBV Binding
por: Schildt, Anna, et al.
Publicado: (2020)